As of 2024-12-14, the EV/EBITDA ratio of Treace Medical Concepts Inc (TMCI) is -9.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TMCI's latest enterprise value is 508.37 mil USD. TMCI's TTM EBITDA according to its financial statements is -54.01 mil USD. Dividing these 2 quantities gives us the above TMCI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.6x - 23.3x | 21.2x |
| Forward P/E multiples | 21.5x - 27.1x | 23.8x |
| Fair Price | (19.32) - (20.82) | (20.12) |
| Upside | -357.6% - -377.7% | -368.3% |
| Date | EV/EBITDA |
| 2024-12-13 | -9.44 |
| 2024-12-12 | -9.56 |
| 2024-12-11 | -9.79 |
| 2024-12-10 | -9.87 |
| 2024-12-09 | -9.90 |
| 2024-12-06 | -9.91 |
| 2024-12-05 | -9.70 |
| 2024-12-04 | -10.06 |
| 2024-12-03 | -10.62 |
| 2024-12-02 | -10.89 |
| 2024-11-29 | -10.59 |
| 2024-11-27 | -10.64 |
| 2024-11-26 | -10.31 |
| 2024-11-25 | -10.32 |
| 2024-11-22 | -9.79 |
| 2024-11-21 | -9.92 |
| 2024-11-20 | -9.97 |
| 2024-11-19 | -9.71 |
| 2024-11-18 | -9.26 |
| 2024-11-15 | -9.54 |
| 2024-11-14 | -9.56 |
| 2024-11-13 | -9.90 |
| 2024-11-12 | -10.04 |
| 2024-11-11 | -10.32 |
| 2024-11-08 | -10.04 |
| 2024-11-07 | -9.87 |
| 2024-11-06 | -9.74 |
| 2024-11-05 | -7.41 |
| 2024-11-04 | -7.02 |
| 2024-11-01 | -6.28 |
| 2024-10-31 | -6.14 |
| 2024-10-30 | -6.29 |
| 2024-10-29 | -6.32 |
| 2024-10-28 | -6.34 |
| 2024-10-25 | -6.17 |
| 2024-10-24 | -6.45 |
| 2024-10-23 | -6.62 |
| 2024-10-22 | -6.89 |
| 2024-10-21 | -6.94 |
| 2024-10-18 | -6.92 |
| 2024-10-17 | -6.86 |
| 2024-10-16 | -6.96 |
| 2024-10-15 | -6.90 |
| 2024-10-14 | -6.76 |
| 2024-10-11 | -6.83 |
| 2024-10-10 | -6.62 |
| 2024-10-09 | -6.79 |
| 2024-10-08 | -6.74 |
| 2024-10-07 | -6.81 |
| 2024-10-04 | -6.92 |